New, promising oral HIV medication receives promising results in late-stage trialMerck's drug is an antiretroviral treatment, a combination of medicines used to stop the reproduction of the virus. FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection.(photo credit: Anamaria Mejia. Via Shutterstock)
